Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on May 9, 2007
J Am Soc Nephrol 18: 1789-1795, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006091062

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006091062v1
18/6/1789    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneshiro, Y.
Right arrow Articles by Itoh, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneshiro, Y.
Right arrow Articles by Itoh, H.

Pathophysiology of Renal Disease and Progression

Slowly Progressive, Angiotensin II–Independent Glomerulosclerosis in Human (Pro)renin Receptor–Transgenic Rats

Yuki Kaneshiro*, Atsuhiro Ichihara*, Mariyo Sakoda*, Tomoko Takemitsu*, A.H.M. Nurun Nabi{dagger}, M. Nasir Uddin{dagger}, Tsutomu Nakagawa{ddagger}, Akira Nishiyama§, Fumiaki Suzuki{dagger},{ddagger}, Tadashi Inagami|| and Hiroshi Itoh*

* Department of Internal Medicine, Keio University School of Medicine, Tokyo, {dagger} United Graduate School of Agricultural Science and {ddagger} Faculty of Applied Biological Sciences, Gifu University, Gifu, and § Department of Pharmacology, Kagawa University School of Medicine, Kagawa, Japan; and || Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee

Address correspondence to: Dr. Atsuhiro Ichihara, Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. Phone: +81-3-5363-3796; Fax: +81-3-5363-3980; E-mail: atzichi{at}sc.itc.keio.ac.jp

Received for publication September 28, 2006. Accepted for publication March 23, 2007.

For defining the pathogenic effects of the (pro)renin receptor–transgenic rat, strains that overexpressed the human receptor were generated. Although transgenic rats were normotensive and euglycemic and had a renal angiotensin II (AngII) level that was comparable to that of wild-type rats, transgenic rats developed proteinuria with aging and significant glomerulosclerosis at 28 wk of age. In kidneys of 28-wk-old transgenic rats, mitogen-activated protein kinases (MAPK) were activated without recognizable tyrosine phosphorylation of the EGF receptor, and expression of TGF-beta1 was enhanced. In vivo infusion of the (pro)renin receptor blocker peptide (formerly handle region decoy peptide) significantly inhibited the development of glomerulosclerosis, proteinuria, MAPK activation, and TGF-beta1 expression in the kidneys, but the angiotensin-converting enzyme inhibitor did not attenuate these changes despite a significant decrease in the renal AngII level. In addition, recombinant rat prorenin stimulated MAPK activation in the human receptor–expressed cultured cells, but human receptor was unable to evoke the enzyme activity of rat prorenin. Thus, human (pro)renin receptor elicits slowly progressive nephropathy by AngII-independent MAPK activation in rats. This study clearly provided in vivo evidence for the AngII-independent MAPK activation by human (pro)renin receptor and induction of glomerulosclerosis with increased TGF-beta1 expression.




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Questions & Answers -- Understanding the Renin System
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 247 - 249.
[PDF]


Home page
Am. J. Pathol.Home page
J. L. Wilkinson-Berka
Prorenin and the (Pro)renin Receptor in Ocular Pathology
Am. J. Pathol., December 1, 2008; 173(6): 1591 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida
(Pro)renin Receptor Promotes Choroidal Neovascularization by Activating Its Signal Transduction and Tissue Renin-Angiotensin System
Am. J. Pathol., December 1, 2008; 173(6): 1911 - 1918.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. W Batenburg and A. J. Danser
Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184.
[PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. J. Danser and G. Nguyen
Spotlight on Renin: The Renin Academy Summit: advancing the understanding of renin science
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 119 - 123.
[PDF]


Home page
Exp PhysiolHome page
H. M. Siragy and J. Huang
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity
Exp Physiol, May 1, 2008; 93(5): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
G. Nguyen and A. H. J. Danser
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents
Exp Physiol, May 1, 2008; 93(5): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Feldt, U. Maschke, R. Dechend, F. C. Luft, and D. N. Muller
The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 743 - 748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. V. Durvasula and S. J. Shankland
Activation of a local renin angiotensin system in podocytes by glucose
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F830 - F839.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. N. Muller, B. Klanke, S. Feldt, N. Cordasic, A. Hartner, R. E. Schmieder, F. C. Luft, and K. F. Hilgers
(Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats
Hypertension, March 1, 2008; 51(3): 676 - 681.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. Bader
Spotlight on Renin: The second life of the (Pro)renin receptor
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2007; 8(4): 205 - 208.
[PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP